Charles River Laboratories International Company

Charles River Laboratories International provides research models and outsourced preclinical services for the accelerated R&D of drugs.
Technology: Drug Delivery
Industry: AI, Early Drug Development
Headquarters: Wilmington, Massachusetts, United States
Founded Date: 1947-01-01
Employees Number: 5001-10000
Funding Status: IPO
Acquisitions Number: 32
Investors Number: 1
Total Funding: 1534000000
Estimated Revenue: $500M to $1B
Last Funding Date: 2021-03-23
Last Funding Type: Post-IPO Debt

Visit Website
https://www.twitter.com/criverlabs
Register and Claim Ownership